Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

類似資料

• Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
  著者:: Shiwen, X, 等
  出版事項: (2006)
• Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
  著者:: S. Soldano, 等
  出版事項: (2011-01-01)
• Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
  著者:: Alix Naert, 等
  出版事項: (2013-01-01)
• CTGF overexpressing mice: a model for human scleroderma
  著者:: Sonnylal, S, 等
  出版事項: (2006)
• Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
  著者:: Emma Di Poi, 等
  出版事項: (2023-11-01)